What we’re building Drug development is one of the most data-intensive endeavors in history, yet scientists spend more time finding and cleaning data than using it. Bioprocess data is high-frequency, multi-source, and scattered across systems that rarely talk to each other. We make it usable, and our AI agent lets scientists query their full experimental […]
Implementation Manager at Invert — United States Read More »
What we’re building Drug development is one of the most data-intensive endeavors in history, yet scientists spend more time finding and cleaning data than using it. Bioprocess data is high-frequency, multi-source, and scattered across systems that rarely talk to each other. We make it usable, and our AI agent lets scientists query their full experimental
Solutions Engineer at Invert — United States Read More »
WHAT WE’RE BUILDING Drug development is one of the most data-intensive endeavors in human history. Yet scientists spend more time finding and cleaning data than actually using it, slowing down drugs that should reach patients faster and more affordably. Biopharma has seen billions invested in software. Almost none of it was built for the scientists
Director of Strategic Accounts – NA at Invert — Europe Read More »